We can’t show the full text here under this license.
Abstract
A 52-year-old woman developed a functional small bowel obstruction after a dose escalation of Zepbound.
- The patient had no prior history of abdominal surgery or gastrointestinal interventions.
- Functional small bowel obstruction occurred despite the absence of conventional risk factors.
- Zepbound is a medication prescribed for weight loss that may be linked to gastrointestinal motility issues.
- This case suggests a need for caution regarding potential severe gastrointestinal complications with Zepbound.
Simplified